Adenosine receptor targeting in health and disease
- 22 October 2011
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Investigational Drugs
- Vol. 20 (12), 1591-1609
- https://doi.org/10.1517/13543784.2011.627853
Abstract
Introduction: The adenosine receptors A1, A2A, A2B and A3 are important and ubiquitous mediators of cellular signaling that play vital roles in protecting tissues and organs from damage. In particular, adenosine triggers tissue protection and repair by different receptor-mediated mechanisms, including increasing the oxygen supply:demand ratio, pre-conditioning, anti-inflammatory effects and the stimulation of angiogenesis. Areas covered: The state of the art of the role of adenosine receptors which have been proposed as targets for drug design and discovery, in health and disease, and an overview of the ligands for these receptors in clinical development. Expert opinion: Selective ligands of A1, A2A, A2B and A3 adenosine receptors are likely to find applications in the treatment of pain, ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature. The aim of this review is to provide an overview of the present knowledge regarding the role of these adenosine receptors in health and disease.Keywords
This publication has 100 references indexed in Scilit:
- Stimulation of the P2X7 receptor kills rat retinal ganglion cells in vivoExperimental Eye Research, 2010
- Activation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2010
- The A3 adenosine receptor attenuates the calcium rise triggered by NMDA receptors in retinal ganglion cellsNeurochemistry International, 2010
- Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across speciesExperimental Eye Research, 2010
- Adenosine A1 receptors regulate bone resorption in mice: Adenosine A1 receptor blockade or deletion increases bone density and prevents ovariectomy‐induced bone loss in adenosine A1 receptor–knockout miceArthritis & Rheumatism, 2010
- The adenosinergic immunomodulatory drugsCurrent Opinion in Pharmacology, 2009
- A2B adenosine receptors in immunity and inflammationTrends in Immunology, 2009
- Adenosine Receptors and CancerPublished by Springer Science and Business Media LLC ,2009
- Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in ratsThe Esophagus, 2009
- Physiological roles for ecto-5’-nucleotidase (CD73)Purinergic Signalling, 2006